Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by fasttrack5on Jan 13, 2022 8:29pm
222 Views
Post# 34315210

RE:RE:RE:RE:RE:RE:RE:RE:News letter

RE:RE:RE:RE:RE:RE:RE:RE:News letter
canadafan wrote:

Unnotable is , to use his words FOS.
first, Onc has had multiple runs beyond a few days.
Most recent being a nice spike upwards of well above $4 ( usd) , last 18 months.
and near $8 ( usd), within last 4 yrs.
a quick trend check can verify that.

other point he keeps spewing utter 180 deg off base in institutional  holdings.
As of year end ( for Q4), institutional holdings, both in numbers of institutions & volume much more than doubled.
Granted , not a large element to start with, but certainly not zero , and not declining.
I agree, the SP has been tenuous. 
why ?
recall the spike Dec 20/19.( all in us$)
the SP was spiking from just about $1, to well above $4 within 2 weeks.
It was moving 40% to 60%/ day.
" what happened & why"
Three major drivers.
1. large short holding then ,.. short squeeze 
2. Aware-1 speculation
3. Year end funds rebalance & insider buys 

Why does the price fall back after jumps?
profit taking, shorting, etc etc.
markets do that.
The long game question, is what is the true value of Onc shares?
Books are written on " market values".
Step back from the question.
why would anyone buy shares of a company?
if Your answer is not " to make $" then you are in an alternative universe I know little about.
So, agreeing that we are here to make $ on our shares, the next point becomes when, how & how much.
Great book. " It's when you sell that counts".
Most investors, sell too late, or too soon.
Most investors, buy to late.
Back to Onc :
Analyst using forward looking math, based on projections, based on the most up to date data they are provided, from Onc have numbers of $6ps to $15ps.
Provided they accomplish various milestones etc etc.
All said & my bottom line.
I believe Pela works & its applications have been expanded last 12 months.
hence the additional co- therapy trials, with Irene, ( triple neg), leukaemia, CAR-t, and G.I. Goblet.
So, yes it is fun to watch day to day swings & the day traders having their way.
I'll wait, because I can.
The options are always, buy, sell or hold.
Two weeks ago, I was buying " more".
I hold a core amount. I have sold on the previous mentioned spikes. Only to buy back in in the dips.
My core holdings,? Partnership, Buyout etc & not before.
 

Well said CF 

 

 



<< Previous
Bullboard Posts
Next >>